GGrantIndex
← Leaderboards

Dong Feng Chen

Schepens Eye Research Institute

$10,365,160
Attributed
$14,556,831
Total exposure
13
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$14,556,831 · 12
VA$0 · 1

By mechanism

R01$10,923,467 · 4
R44$1,480,057 · 1
R21$1,071,125 · 2
P30$518,799 · 1
R43$245,148 · 1
R41$233,235 · 1

Top collaborators

Most similar at Schepens Eye Research Institute

Same institution · by research overlap

Others in their field

Top investigators on “Brain

Research focus

BrainOptic NerveEventNeuronsBlindnessGlaucomaVisionAxonSignal TransductionRetinal Ganglion CellsMolecularNeurodegenerative DisordersMediatingLaboratoriesLeadCellsInjuryRetinaNatural RegenerationMouse ModelResearch PersonnelCell SurvivalAffectRelating To Nervous System

Grant awards (43)

Innate and Adaptive Immunity in the Pathogenesis of Glaucoma$610,152
R01 · FY2025 · EY · contact PI
The 9th Military Vision Symposium on Novel Technology and Vision Restoration.$45,000
R13 · FY2025 · EY · contact PI
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma$717,827
R01 · FY2024 · EY · contact PI
Computer vision powered automation of rodent arena for assessment of early Alzheimer's disease.$245,148
R43 · FY2024 · AG
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma$140,834
R01 · FY2024 · EY · contact PI
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma$717,827
R01 · FY2023 · EY · contact PI
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma$504,370
R01 · FY2023 · EY · contact PI
Histone and DNA methyltransferases in optic nerve regeneration$295,500
R21 · FY2023 · EY · contact PI
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma$696,292
R01 · FY2022 · EY · contact PI
Histone and DNA methyltransferases in optic nerve regeneration$246,250
R21 · FY2022 · EY · contact PI
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma$181,348
R01 · FY2022 · EY · contact PI
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma$760,417
R01 · FY2021 · EY · contact PI
Flow Cytometry Module$103,760
P30 · FY2021 · EY · contact PI
The 7th Military Vision Symposium on Ocular Readiness for Military Conflicts and Civilian Casualties$40,000
R13 · FY2021 · EY · contact PI
Development of a Next Generation Visual Performance Assessment System for Rodents$691,652
R44 · FY2020 · EY
The Molecular Basis Underlying Optic Nerve Growth in Development and Regeneration$492,500
R01 · FY2020 · EY · contact PI
Flow Cytometry Module$103,760
P30 · FY2020 · EY · contact PI
Development of a Next Generation Visual Performance Assessment System for Rodents$788,405
R44 · FY2019 · EY
The Molecular Basis Underlying Optic Nerve Growth in Development and Regeneration$492,500
R01 · FY2019 · EY · contact PI
Flow Cytometry Module$103,759
P30 · FY2019 · EY · contact PI
The Molecular Basis Underlying Optic Nerve Growth in Development and Regeneration$500,109
R01 · FY2018 · EY · contact PI
The Molecular Basis Underlying Optic Nerve Growth in Development and Regeneration$492,500
R01 · FY2018 · EY · contact PI
Flow Cytometry Module$103,760
P30 · FY2018 · EY · contact PI
The Molecular Basis Underlying Optic Nerve Growth in Development and Regeneration$102,693
R01 · FY2018 · EY · contact PI
The Molecular Basis Underlying Optic Nerve Growth in Development and Regeneration$492,500
R01 · FY2017 · EY · contact PI
Flow Cytometry Module$103,760
P30 · FY2017 · EY · contact PI
The Molecular Basis Underlying Optic Nerve Growth in Development and Regeneration$102,693
R01 · FY2017 · EY · contact PI
The Molecular Basis Underlying Optic Nerve Growth in Development and Regeneration$492,500
R01 · FY2016 · EY · contact PI
A Visual Assessment System for Retinal Function/Drug Discovery$233,235
R41 · FY2015 · EY
Biological Inquiry into the Mechanisms and Neuroprotective Strategy for TBI$0
I01 · FY2014 · VA · contact PI
Biological Inquiry into the Mechanisms and Neuroprotective Strategy for TBI$0
I01 · FY2013 · VA · contact PI
Functional Restoration of the Optic Nerve After Disease or Damage$484,069
R01 · FY2010 · EY · contact PI
Glial Modulation of Cortical Development and Drug of Abuse-induced Brain Damage$240,625
R21 · FY2010 · DA · contact PI
Functional Restoration of the Optic Nerve After Disease or Damage$481,250
R01 · FY2009 · EY · contact PI
Glial Modulation of Cortical Development and Drug of Abuse-induced Brain Damage$288,750
R21 · FY2009 · DA · contact PI
Biological Inquiry into the Mechanisms and Neuroprotective Strategy for TBI$0
I01 · FY2009 · VA · contact PI
Functional Restoration of the Optic Nerve After Disease or Damage$486,250
R01 · FY2008 · EY · contact PI
MOLECULAR MECHANISMS UNDERLYING OPTIC NERVE REGENERATION$127,596
R01 · FY2005 · EY
MOLECULAR MECHANISMS UNDERLYING OPTIC NERVE REGENERATION$372,000
R01 · FY2004 · EY
MOLECULAR MECHANISMS UNDERLYING OPTIC NERVE REGENERATION$372,000
R01 · FY2003 · EY
MOLECULAR MECHANISMS UNDERLYING OPTIC NERVE REGENERATION$348,000
R01 · FY2002 · EY
MOLECULAR MECHANISMS UNDERLYING OPTIC NERVE REGENERATION$364,500
R01 · FY2001 · EY
MOLECULAR MECHANISMS UNDERLYING OPTIC NERVE REGENERATION$390,740
R01 · FY2000 · EY